RU93058622A -
COMPOSITIONS BASED ON THE LELISTAD FACTOR, VACCINES, DIAGNOSTIC KITS, DIAGNOSTIC METHOD
- Google Patents
COMPOSITIONS BASED ON THE LELISTAD FACTOR, VACCINES, DIAGNOSTIC KITS, DIAGNOSTIC METHOD
Info
Publication number
RU93058622A
RU93058622ARU93058622/13ARU93058622ARU93058622ARU 93058622 ARU93058622 ARU 93058622ARU 93058622/13 ARU93058622/13 ARU 93058622/13ARU 93058622 ARU93058622 ARU 93058622ARU 93058622 ARU93058622 ARU 93058622A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Стихтинг Сентрал Диргенэскюндиг ИнститютfiledCriticalСтихтинг Сентрал Диргенэскюндиг Инститют
Publication of RU93058622ApublicationCriticalpatent/RU93058622A/en
Application grantedgrantedCritical
Publication of RU2124051C1publicationCriticalpatent/RU2124051C1/en
Состав вещества, включающего в себя этиологический фактор таинственного заболевания свиней - фактор Лелистада - в живой, ослабленной, мертвой или рекомбинантной форме, или часть, или компоненту его. Вакцинные составы и диагностические наборы, основанные на таковых. Рекомбинантная нуклеиновая кислота, включающая в себя фактор Лелистада, - специфическая нуклеотидная последовательность. Пептиды, включающие в себя фактор Лелистада, - специфическая аминокислотная последовательность. Фактор Лелистада - специфические антитела.The composition of the substance, which includes the etiological factor of the mysterious disease of pigs - the Lelystad factor - in living, weakened, dead or recombinant form, or a part or component of it. Vaccine formulations and diagnostic kits based on those. Recombinant nucleic acid, which includes the Lelystad factor, is a specific nucleotide sequence. Peptides including the Lelystad factor are a specific amino acid sequence. Lelystad factor - specific antibodies.
RU93058622/13A1991-06-061992-06-05Composition based on lelistad factor (variants), vaccine (variants), diagnostic set (variants) and method of diagnosis
RU2124051C1
(en)
"recombinant turkey herpes virus (hvt), recombinant hvt, nucleic acid sequence, molecupara the preparation of a recombinant hvt, culture a vaccine, process for the preparation of a vaccine, pharmaceutical or diagnostic composition and antiserum"
TUMOR ASSOCIATED ANTIGEN DERIVATIVES OF THE MAGE FAMILY, NUCLEIC ACID SEQUENCES THAT CODE FOR THE PREPARATION OF FUSION PROTEINS AND COMPOSITIONS FOR VACCINATION
Monoclonal and polyclonal antibodies, peptide capable of generating an antibody, immunogenic agent, nucleotide sequence, pharmaceutical composition, use of at least one antibody, diagnostic kit, and process for preparing an immunogenic agent
Immunogenic peptide derived from subgroup a or b vrs protein g, nucleic acid sequence, pharmaceutical composition, polyclonal or monoclonal antibodies, diagnostic kit, use of an immunogenic peptide, and, conjugate
A method for the preparation of molecules bearing at least one peptidic sequence of one or more EPITOPO (S) characteristic of a protein produced by P. falciparum at the level of the testosterone stage and in the hepatocytes